Kirpekar Sahil
CIK 0001951712
Chief Business Officer
Filings
5
Latest Mar 24, 2025
Issuers covered
1
Showing
5 of 5
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -5.9% | -5.9% | +2.1% | -13.9% |
| 90 days | 2 | 50% | -21.6% | -21.6% | +27.8% | -71.0% |
| 180 days | 2 | 50% | -90.0% | -90.0% | +38.0% | -217.9% |
| 365 days | 2 | 50% | -56.5% | -56.5% | +20.9% | -133.8% |
Issuers
Companies where Kirpekar Sahil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATAI | Atai Life Sciences N.V. | 5 | Mar 24, 2025 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|